Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)

China flag China · Delayed Price · Currency is CNY
18.19
-0.04 (-0.22%)
At close: Apr 29, 2026
-0.66%
Market Cap 15.18B
Revenue (ttm) 4.20B
Net Income (ttm) 462.64M
Shares Out 832.47M
EPS (ttm) 0.55
PE Ratio 33.03
Forward PE 28.48
Dividend 0.18 (0.99%)
Ex-Dividend Date Dec 22, 2025
Volume 5,796,702
Average Volume 4,511,607
Open 18.08
Previous Close 18.23
Day's Range 18.04 - 18.40
52-Week Range 15.95 - 22.95
Beta 0.54
RSI 62.76
Earnings Date Apr 28, 2026

About Huaxia Eye Hospital Group

Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis and treatment services for patients with ophthalmic diseases; and myopia prevention and intervention work to the public. It offers services in the areas of cataract, refraction, fundus, strabismus and amblyopia, pediatric ophthalmology, ocular surface, glaucoma, orbital and ocular tumors, and ocular trauma. The company was founded in 1997 and is based in Xiamen, China. [Read more]

Sector Healthcare
Founded 1997
Employees 7,883
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301267
Full Company Profile

Financial Performance

In 2025, Huaxia Eye Hospital Group's revenue was 4.14 billion, an increase of 2.78% compared to the previous year's 4.03 billion. Earnings were 440.65 million, an increase of 2.80%.

Financial Statements

News

There is no news available yet.